Question

Difficulty: Very hardPreventive Care and Screening

Match each patient's clinical scenario with the most appropriate guideline-concordant preventive care and screening strategy.

  • During a routine health maintenance evaluation, a 68-year-old female patient reports a past medical history significant for cervical intraepithelial neoplasia grade 2 (CIN-2) that was definitively treated at age 55. Her last Pap and HPV cotesting performed at age 64 yielded negative results.Maintain routine surveillance intervals despite advanced age due to a prior high-grade precancerous lesion.
  • Evaluation of a 75-year-old male with severe, oxygen-dependent chronic obstructive pulmonary disease reveals a remote 40 pack-year smoking history prior to quitting 8 years ago.Cease routine screening protocols as severe comorbidities preclude curative surgical intervention.
  • A 42-year-old asymptomatic male provides an updated family pedigree revealing that his father was diagnosed with colorectal cancer at 50 years of age.Initiate specialized screening immediately with shortened 5-year surveillance intervals.
  • Following a new diagnosis of HIV infection, a 32-year-old male with a baseline CD4 count of 450 cells/mm³ is reviewed for immunization deficits. He has not received any vaccinations since adolescence.Administer targeted adult immunization indicated by a new-onset immunocompromising condition.
  • A healthy 35-year-old female of Ashkenazi Jewish descent inquires about cancer risk mitigation after discovering her paternal grandmother succumbed to ovarian cancer at age 65.Refer for formal familial risk assessment based on ancestry and second-degree relative history.

Answer

The clinical scenarios map to highly specific guideline exceptions: extending cervical screening for 25 years post-CIN-2, stopping LDCT due to limited surgical candidacy, accelerating colorectal screening to a 5-year interval starting at age 40 due to high-risk family history, administering PCV20 for new-onset HIV, and referring for BRCA genetic counseling based on Ashkenazi ancestry and second-degree family history.
Each correct pairing represents a critical nuance in preventive care guidelines where standard, average-risk protocols are overridden by specific historical, demographic, or physiologic factors.

Step-by-Step Solution

1
Evaluate the 68-year-old female's cervical cancer screening cessation criteria.
Determine that routine age-based cessation does not apply.
The history of CIN-2 treated at age 55 triggers a 25-year post-treatment surveillance mandate, requiring screening to continue until at least age 80.
2
Analyze the 75-year-old male's eligibility for lung cancer screening with LDCT.
Determine that LDCT is contraindicated despite his qualifying 40 pack-year smoking history.
Guidelines mandate cessation of LDCT if the patient develops a health problem (like end-stage COPD on continuous oxygen) that limits life expectancy or the ability to undergo curative surgery.
3
Assess the 42-year-old male's colorectal cancer screening requirements.
Determine he requires immediate screening with an accelerated follow-up interval.
Having a first-degree relative diagnosed with colorectal cancer at age 50 dictates starting screening at age 40 (10 years prior to the relative's diagnosis) and repeating the colonoscopy every 5 years.
4
Identify the adult immunization needs for the 32-year-old male with HIV.
Determine he requires pneumococcal vaccination.
HIV is an immunocompromising condition that necessitates pneumococcal immunization (PCV20) in adults under age 65.
5
Evaluate the 35-year-old female's genetic screening risk.
Determine she meets criteria for formal BRCA risk assessment.
Ashkenazi Jewish descent combined with a second-degree relative's history of ovarian cancer is a high-risk profile warranting genetic counseling.

Key Concept

Advanced application of USPSTF and ACIP preventive guidelines, focusing on high-risk demographic modifiers, age-based exceptions, and comorbidity-driven cessation criteria.
Rate this question